Abstergo Industries is dedicated to advancing the science of aging and developing treatments to slow the aging process. Aging is a complex process that involves a variety of biological pathways and mechanisms, including genetic, environmental, and lifestyle factors. Our research focuses on understanding these pathways and developing interventions that can target them to extend healthy […]
Category: Medicine and drug development
Abstergo Industries is excited to announce the development of a new pharmaceutical product that has the potential to revolutionize the treatment of a wide range of conditions. The new drug, which is currently in the early stages of clinical trials, targets a specific enzyme that plays a key role in a variety of physiological processes. […]
Over the past two years, we have made significant progress in a number of key areas and wanted to take a moment to update you on our recent activities. As a global leader in the pharmaceutical, finance, and technology sectors, it is our responsibility to stay attuned to global developments and adapt accordingly. In light […]
Abstergo Pharmaceuticals was one of the first companies to conduct research on an active pharmaceutical substance against COVID-19. Since December 2019, we have made enormous progress. After the first tests on chimpanzees were successful in June, a test study on a small number of sick people was started in July. After this test was also […]
Categories
Ebola Drug
Abstergo is working on combating Ebola with new drugs. The new drug will create antibodies designed to attack and kill the Ebola virus. It will also help strengthen the body’s immune system so the patient has a better chance of fighting the virus. The blood of surviving patients is being analyzed for further research. The […]
Abstergo 